Oxford Biomedica PLC Holding(s) in Company (1690R)
24 Octobre 2023 - 7:17PM
UK Regulatory
TIDMOXB
RNS Number : 1690R
Oxford Biomedica PLC
24 October 2023
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BDFBVT43
Issuer Name
Oxford Biomedica plc
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Vulpes Investment Management Pte Ltd
City of registered office (if applicable)
SG
Country of registered office (if applicable)
Singapore
Name City of registered office Country of registered office
Vulpes Testudo Fund Cayman Islands Cayman Islands
=========================== ==============================
Vulpes Life Sciences Fund Cayman Islands Cayman Islands
=========================== ==============================
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s)
subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
23-Oct-2023
6. Date on which Issuer notified
24-Oct-2023
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 8.720000 0.000000 8.720000 8437978
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 10.120000 0.000000 10.120000
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB00BDFBVT43 8437978 8.720000%
====================== ====================== ====================== ======================
Sub Total 8.A 8437978 8.720000%
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Sub Total 8.B2
========================================================= =================== ==================
9. Information in relation to the person subject to the
notification obligation
1. Person subject to the notification obligation is not
controlled by any natural person or legal entity and does not
control any other undertaking(s) holding directly or indirectly an
interest in the (underlying) issuer.
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is higher through financial equals or is higher
than the notifiable instruments if it than the notifiable
threshold equals or is higher threshold
than the notifiable
threshold
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
24-Oct-2023
13. Place Of Completion
London, UK
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUSABROVURUAA
(END) Dow Jones Newswires
October 24, 2023 13:17 ET (17:17 GMT)
Oxford Biomedica (AQSE:OXB.GB)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Oxford Biomedica (AQSE:OXB.GB)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024
